Litigation

Recent Posts

Hezekiah Sistrunk Appointed To DePuy Hip Implant Discovery Committee
Posted on 2 Feb 2011 by LexisNexis Litigation Resource Community Staff

ATLANTA - Attorney Hezekiah Sistrunk Jr. of The Cochran Firm - Atlanta has been selected for a leadership position in the DePuy ASR Hip Implant mass tort multidistrict litigation. Federal Judge David A. Katz appointed Sistrunk to the Discovery Committee... Read More

J&J, FDA Leaders Take Heat For Phantom Recall'
Posted on 30 Sep 2010 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) Johnson & Johnson executives and the Food and Drug Administration both shouldered the blame Thursday for a secret recall in which hired contractors quietly bought up defective painkillers to clear them from store shelves. J&J... Read More

FDA Sees Possible Cancer Risk With Breast Implants
Posted on 1 Feb 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) Federal health officials said Wednesday they are investigating a possible link between breast implants and a very rare form of cancer, raising new questions about the safety of devices which have been scrutinized for decades. The... Read More

A Look At J&J's Year-Long String Of Recalls
Posted on 30 Sep 2010 by LexisNexis Litigation Resource Community Staff

(AP) Two top executives from Johnson & Johnson faced tough questions Thursday from lawmakers holding the second hearing on the company's unprecedented string of product recalls. The maker of trusted brands like Tylenol and Benadryl, J&J has... Read More

Johnson & Johnson Ordered To Pay $258M To Louisiana
Posted on 17 Oct 2010 by LexisNexis Litigation Resource Community Staff

OPELOUSAS, La. - (AP) A Louisiana jury says health products maker Johnson & Johnson owes the state nearly $258 million for misleading doctors about the possible side effects of one of its anti-psychotic medications. Full version available to lexis... Read More

McNeil Pleads Guilty, Pays $25M For Making Adulterated Children’s Medicines
Posted on 11 Mar 2015 by Tom Moylan

PHILADELPHIA — (Mealey’s) The McNeil-PPC Inc. subsidiary of Johnson & Johnson on March 10 pleaded guilty to a federal misdemeanor criminal charge of making adulterated children’s over-the-counter medicines and agreed to pay a criminal... Read More

Johnson & Johnson, 2 Units Plead Guilty, Pay $2.2 Billion In Criminal, Civil Penalties
Posted on 4 Nov 2013 by Tom Moylan

WASHINGTON, D.C. — (Mealey’s) Two Johnson & Johnson subsidiaries have pleaded guilty, and the parent company and two subsidiaries will pay $2.2 billion in criminal fines, civil penalties and forfeitures in one criminal and several civil... Read More

Jury Awards $1.8 Million To Plaintiff In First Levaquin MDL Bellwether Trial
Posted on 9 Dec 2010 by Tom Moylan

MINNEAPOLIS - (Mealey's) A Minnesota federal jury on Dec. 8 awarded a plaintiff in the first Levaquin multidistrict litigation bellwether trial a total of $1,815,000 in compensatory and punitive damages after finding that manufacturer Ortho-McNeil... Read More

California Jury Awards $5.7 Million In Ethicon Pelvic Mesh Trial
Posted on 7 Mar 2015 by Tom Moylan

BAKERSFIELD, Calif. — (Mealey’s) A California state court jury on March 5 awarded $5.7 million to a plaintiff in an Ethicon pelvic mesh injury trial ( Colleen Perry, et al. v. Ethicon Inc., et al. , No. S-1500-CV-279123, Calif. Super., Kern... Read More

Jury Awards $7.76 Million In Punitive Damages In New Jersey's 1st Pelvic Mesh Trial
Posted on 28 Feb 2013 by Tom Moylan

ATLANTIC CITY, N.J. - (Mealey's) A New Jersey court on Feb. 28 ordered the Ethicon Endo-Surgery Inc. subsidiary of Johnson & Johnson to pay $7.76 million in punitive damages to a woman who claims to have debilitating injuries from a Gynecare Prolift... Read More

Pa. Risperdal Off-Label Trial Ends With Nonsuit For Janssen
Posted on 14 Jun 2010 by Tom Moylan

PHILADELPHIA - (Mealey's) A Pennsylvania state court judge on June 14 granted Janssen Pharmaceutica Inc.'s motion for a nonsuit of the state government's third-party payer suit alleging that the drug company's off-label marketing of its... Read More

Boston Scientific Pays $600 Million To Settle Guidant Contract Suit By Johnson & Johnson
Posted on 18 Feb 2015 by Tom Moylan

MARLBOROUGH, Mass. — (Mealey’s) Boston Scientific Corp. on Feb. 17 announced that it has agreed to pay Johnson & Johnson (J&J) $600 million to settle a nine-year-old lawsuit alleging that Guidant Corp., which is now a Boston Scientific... Read More

Pennsylvania State Court Jury Awards $2.5 Million In Risperdal Gynecomastia Trial
Posted on 24 Feb 2015 by Tom Moylan

PHILADELPHIA — (Mealey’s) A Pennsylvania state court jury on Feb. 24 awarded $2.5 million to the family of a man who claimed that the atypical antipsychotic drug Risperdal caused gynecomastia, or enlarged male breasts ( P.P., et al. v. Ortho... Read More

U.S. Supreme Court Won't Take Up Preemption Of Over-The-Counter Drugs
Posted on 9 Oct 2012 by Tom Moylan

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on Oct. 9 denied a petition by a Johnson & Johnson subsidiary asking the high court to find that state law failure-to-warn claims involving over-the-counter (OTC), nonprescription drugs are... Read More

DePuy To Pay $2.5 Billion To Settle National ASR Hip Litigation, Parties Announce
Posted on 20 Nov 2013 by Tom Moylan

WARSAW, Ind. — (Mealey’s) The DePuy Orthopaedics Inc. subsidiary of Johnson & Johnson will pay $2.5 billion to settle about 8,000 claims involving its recalled ASR hip prosthesis, according to a joint announcement Nov. 19 by the company... Read More